Test Price
2,800 AED✅ Home Collection Available
PRKAR1A Gene Myxoma, Intracardiac Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Executive Summary
This PRKAR1A gene sequencing test detects pathogenic variants associated with Carney complex and intracardiac myxoma using next-generation sequencing (NGS) with >99.9% diagnostic sensitivity.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019.
Test Overview & Methodology
This next-generation sequencing (NGS) test fully analyses the PRKAR1A gene to detect pathogenic variants causing Carney complex and intracardiac myxoma, delivering clinical-grade precision and risk stratification. NGS enables comprehensive coverage of all coding exons and flanking intronic regions, detecting single-nucleotide variants and small insertions/deletions with high sensitivity.
| Feature | Our Test (NGS Pan-Gene Analysis) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – full gene coverage | Sanger sequencing – limited to known hotspots |
| Diagnostic Sensitivity | >99.9% for single-nucleotide variants and indels | ~95% for targeted regions only |
| Turnaround Time | 3–4 Weeks | 2–4 Weeks |
| ISO 9001:2015 Certified | Yes (Cert: INT/EGQ/2509DA/3139) | Often not guaranteed |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Genetics, I emphasize that this test must be correlated with clinical imaging, cardiologic evaluation, and detailed family history. Genetic findings guide surveillance—they never replace clinical judgement. Do not alter any prescribed therapy without direct medical consultation.”
– Lina Osama Zaki Quteineh, DHA License: 9294403
Advisory: Medication Safety
Do not discontinue prescribed medication without consulting your doctor. Genetic test results are for risk assessment and should not replace current treatment plans without physician guidance.
Exclusion Criteria & Emergency Red Flags
- Individuals unable to provide informed consent; minors require legal guardian consent per UAE Federal Law No. 2 of 2019.
- Known pregnancy is not a contraindication, but clinical interpretation may need adjustment; discuss with your physician.
- Emergency Red Flags:
- Chest pain, palpitations, transient ischemic attack, or sudden neurological deficits — seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What does the PRKAR1A gene test detect, and why is it critical for cardiac myxoma?
The PRKAR1A NGS test identifies pathogenic mutations in the PRKAR1A gene linked to Carney complex and intracardiac myxoma, enabling precise risk stratification, early surveillance, and informed family counselling.
2. How is the sample collected, and what is the turnaround time?
A whole blood, extracted DNA, or dried blood spot on an FTA card is collected via our VIP Mobile Phlebotomy and Temperature-Controlled Cold-Chain Home Collection service, available daily from 8 AM to 11 PM. Results are reported within 3 to 4 weeks using ISO‑certified NGS.
3. Is this test covered by UAE health insurance, and how can I verify?
Many UAE insurance plans cover genetic testing for clinical suspicion of Carney complex; we provide direct billing verification via WhatsApp at +971 54 548 8731 before sample collection.
UAE Regulatory & Data Privacy Adherence
This test is performed in compliance with UAE Federal Decree-Law No. 45 of 2021 on the Protection of Personal Data (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is securely handled and stored in accordance with these regulations to ensure patient confidentiality and data integrity.
Clinical & Logistical Metadata
| Test Name | PRKAR1A Gene Myxoma, Intracardiac Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene coverage |
| ICD-10-CM Code | D15.1 (Benign neoplasm of heart) |
| LOINC Code | 21636-6 (PRKAR1A gene mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians